Front Endocrinol (Lausanne)
March 2023
Background: MAFLD is the most common cause of chronic liver disease, affecting 25% of the global population. Patients with T2DM have an increased risk of developing MAFLD. In addition, patients with T2DM have a higher risk of advanced forms of steatohepatitis and fibrosis.
View Article and Find Full Text PDFEndocrinol Diabetes Nutr (Engl Ed)
April 2022
Endocrinol Diabetes Nutr (Engl Ed)
June 2021